The National Lung Cancer Screening Program (NLCSP) aims to achieve better health outcomes for Australians by detecting lung cancer early and reducing deaths from lung cancer. Early detection can lead to more effective treatment options and improved outcomes for patients.
The NLCSP is a screening program using low-dose computed tomography (LDCT) scans to look for lung cancer in high-risk people without any symptoms. It is targeted to eligible people aged between 50 to 70 years old with no signs or symptoms of lung cancer.
The program is an Australian Government initiative being implemented in partnership with the National Aboriginal Community Controlled Health Organisation (NACCHO) and Cancer Australia.
The program is being co-designed in partnership with communities and the healthcare workforce to be person-centred, equity-focused, accessible, and culturally safe. It is being co-designed to improve lung cancer outcomes for those disproportionately impacted by lung cancer including Aboriginal and Torres Strait Islander people and communities.
The program will commence from July 2025 and will help prevent over 500 deaths each year from lung cancer.
RANZCR members are uniquely positioned to engage in the program by joining the Australian and New Zealand Society of Thoracic Radiology (ANZSTR). The Special Interest Group is open to all radiologists who report thoracic imaging, for more details visit ranzcr.com/special-interest-groups-anzstr
RANZCR invites all members to actively engage with the National Lung Cancer Screening Program (NLCSP) and get involved with the opportunities it offers to enhance patient care.
Read the RANZCR blog article
RANZCR will be running webinars and workshops on the NLCSP in 2025. Stay tuned for dates!